Valuation: Genix Pharmaceuticals Corporation

Market Cap 918K 644K 584K 540K 487K 60.76M 951K 6.49M 2.57M 32.46M 2.42M 2.37M 103M P/E 2024
-40.5x
P/E 2025 -5.33x
Enterprise Value 1.92M 1.35M 1.22M 1.13M 1.02M 127M 1.99M 13.55M 5.37M 67.77M 5.05M 4.94M 215M EV / Sales 2024
929,496,174x
EV / Sales 2025 -
Free-Float
53.08%
Yield 2024 *
-
Yield 2025 -
1 month-25.00%
6 months-25.00%
Current year-40.00%
1 month 0.02
Extreme 0.015
0.02
Current year 0.02
Extreme 0.015
0.02
1 year 0.02
Extreme 0.015
0.02
3 years 0.02
Extreme 0.015
0.09
5 years 0.02
Extreme 0.015
0.19
10 years 0.01
Extreme 0.01
0.3
Manager TitleAgeSince
Chief Executive Officer 57 03/08/2018
Director of Finance/CFO - 04/05/2026
President - 21/05/2021
Director TitleAgeSince
Director/Board Member 57 03/08/2018
Director/Board Member 76 11/03/2019
Director/Board Member 48 05/09/2019
Date Insider Type Main position Quantity % Market Cap. Importance
09/09/25 Option

Chairman

1,000,000 1.6885%
09/09/25 Option

Chairman

1,000,000 1.6885%
09/09/25 Option

Chief Executive Officer

1,000,000 1.6885%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%-50.00%-62.50% 644K
+1.26%+6.61%+41.12%+135.59% 1,286B
+0.79%+3.45%+46.35%+93.56% 688B
+0.20%+1.28%+27.01%+112.80% 521B
-0.44%+3.69%+39.60%+69.51% 386B
+0.55%+0.70%+59.00%+44.20% 364B
-0.12%+0.74%+26.78%+58.43% 302B
+0.37%+0.37%+3.62%+36.44% 287B
-0.30%+1.14%+38.59%+74.61% 252B
+0.08%+0.71%+34.25%+124.32% 208B
Average +0.24%+1.87%+26.63%+68.69% 429B
Weighted average by Cap. +0.54%+3.26%+37.63%+96.23%

Financials

2024 2025
Net sales 0 0 0 0 0 0.27 0 0.03 0.01 0.14 0.01 0.01 0.45 -
Net income -73.2K -51.36K -46.54K -43.05K -38.84K -4.84M -75.78K -517K -205K -2.59M -193K -189K -8.21M -335K -235K -213K -197K -178K -22.17M -347K -2.37M -939K -11.84M -882K -864K -37.59M
Net Debt 804K 564K 511K 473K 427K 53.2M 833K 5.68M 2.25M 28.42M 2.12M 2.07M 90.22M 999K 701K 635K 588K 530K 66.11M 1.03M 7.06M 2.8M 35.32M 2.63M 2.58M 112M
Projected Income Statement - Annual - Genix Pharmaceuticals Corporation
Logo Genix Pharmaceuticals Corporation
Genix Pharmaceuticals Corporation is a Canadian ophthalmic drugs company. The Company is a formulator, manufacturer, licensor and marketer of life sciences-related products with a focus on nutraceuticals and pharmaceuticals. Its operations consist primarily of the research, development, manufacture, in-licensing and sales of novel and healthcare products, focusing on proprietary over the counter (OTC) nutraceuticals and generic pharmaceuticals. The Company has been marketing and selling other nutraceuticals and some pharmaceutical products, such as bee propolis capsules, calcium liquid softgels, seal oil softgels, marine lipid softgels, Lecithin softgels, fish oil softgels, EPO softgels and spirulina powder. Its products include Ketorolac 0.5% Eye Drops, Timolol 0.5% Eye Drops, Diclofenac 0.1% Eye Drops, Moxifloxacin Hydrochloride 0.5% Eye Drops, Prednisolone Acetate 1% Eye Drops, Olopatadine 0.1% Eye Drops, and others.
Employees
4,000
Date Price Change Volume
  1. Stock Market
  2. Stocks
  3. GENX Stock